Sunday, February 25, 2024
HomeDr. Lalit Kumar

People

Quick Links

Notification Center

Dr. Lalit Kumar

Assistant Professor

Department of Pharmaceutics

National Institute of Pharmaceutical Education & Research Hajipur,

Bihar India – 844 102

E-mail: lalit.kumar@niperhajipur.ac.in;

lalitkumar_pharma@yahoo.co.in

Phone: +919880120144.

Faculty CV

Academics
2016: PhD (Pharmaceutical Sciences) from Manipal University, Manipal, Karnataka, India.

2009: MPharm (Pharmaceutics) from Himalayan Pharmacy Institute, Majhitar, Sikkim, India.

2007: BPharm from Sardar Bhagwan Singh (PG) Institute of Biomedical Sciences & Research, Balawala, Dehradun, Uttrakhan, India.

2003: DPharm from Sri Guru Gobin Singh College of Pharmacy, Sect. 26, Chandigarh, India.

Research Areas

  • Nanoparticulate Drug Delivery Systems
  • Targeted Drug Delivery Systems
  • Transdermal Drug Delivery Systems
  • Topical Drug Delivery Systems
  • Quality by Design and Design of Experiments
  • Analytical and Bioanalytical Method Development and Validations.

Experience

  • Presently working as Assistant Professor in Department of Pharmaceutics, NIPER, Hajipur, Bihar from 19th January 2023.
  • Worked as Assistant Professor in Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences and Research, Delhi Pharmaceutical Sciences & Research University, Pushp Vihar, New Delhi from 8th August 2022 to 18th January 2023.
  • Worked as Assistant Professor – Selection Grade in Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Udupi, Karnataka from 29th November 2010 to 6th August 2022.
  • Worked as Lecturer in Department of Pharmacology, Sikkim Manipal Institute of Medical Sciences, SMU, Gangatok, Sikkim from 15th February 2010 to 20th November 2010.
  • Worked as Lecturer in Department of Pharmaceutics, Himachal Institute of Pharmacy, Paonta Sahib, Sirmour, Himachal Pradesh from 27th July 2009 to 10th February 2010.

Distinctions
Funding Received from the Government Agencies:

S. No. Title or area of research Principal investigator or Co-investigator Scheme Source of Funding Duration of project Status
1. Preparation and characterization of water-soluble nanoparticles of an antihypertensive drug. Co-investigator RPS AICTE 3.0 Years Completed
2. Preparation and characterization of polymeric nanoparticles to enhancement the oral bioavailability of a BCS class II drug. Principal Investigator CAYT AICTE 3.0 Years Completed
3. Design, preparation and characterization of lipid nanoparticles. Principal Investigator SMYSR VGST 1.0 Year Completed
4. Design of experiments in new pharmaceutical formulations development. Program Coordinator STTP AICTE 6.0 Days Completed
5. Lipid nanoparticles of an anticancer agent for the treatment of colon cancer. Principal Investigator EMR SERB 3.0 Years Completed
6. Computational tools for pharmaceutical developments. Program Coordinator STTP AICTE 6.0 Days (Slot-I) 6.0 Days (Slot-II) Completed
7. Formulation and evaluation of orotransmucosal film strips containing nanoparticles of anti-hypertensive agent to enhance its oral bioavailability. Principal Investigator RPS AICTE 3.0 Years Completed
8. Targeted delivery of drugs for the treatment of colorectal cancer. Principal Investigator DHR GIA 3.0 Years Ongoing
9. Development of novel formulation for the treatment of visceral leishmaniasis. Principal Investigator ICMR Special Call 3.0 Years Ongoing

 Research Awards:

  1. Best Poster award for “Vaginal Zidovudine microcapsules for the treatment of heterosexually transmitted HIV infection” presented in Louis Pasteur memorial symposium (ICMR sponsored) National Symposium on Infectious Diseases from 8th August to 9th August 2008, Coimbatore, India.
  2. Second Best Poster award for “Design, preparation and optimization of valsartan polymeric nanoparticles using full factorial design” presented in 3rd International Non-Communicable Diseases (NCD) Research Meet – Manipal Chapter – 2015 from 10th to 11th Jan 2015 at KMC, Manipal University, Manipal, Udupi, Karnataka, India.
  3. First Best Poster award for “Polymeric nanosuspension of gefitinib: In vitro and in vivo characterizations” presented in 68th Indian Pharmaceutical Congress, December 16-18, 2016, Andhra University Campus, Visakhapatnam, AP.
  4. Best oral presentation award for “Design, formulation an evaluation of nanostructured lipid carriers loaded topical cream of fluconazole” presented in 7th Annual International Conference & Exhibition of Society of Pharmaceutical Education & Research [SPER 2018], February 23rd – 24th, 2018, Chennai [Tamil Nadu], India.
  5. M.L. Khorana Memorial Prize under the field “Pharmaceutical Analysis & Bio-analytical Methods” for a best paper entitled “Statistical Optimization of Extraction Process for the Quantification of Valsartan in Rabbit Plasma by a HPLC Method” authored by M. Sreenivasa Reddy, L. Kumar, Z. Attari and R. Verma published in Indian J Pharm Sci. 2017:79(1):16-28. The award received on 22nd December 2018 at Holiday Inn, New Delhi Mayur Vihar Noida, 13A, Mayur Vihar, District Centre, Delhi 110 091 during IPA award function.
  6. Dr TMA Pai Gold Medal for the outstanding research publication for the article “A Quality by Design Approach on Polymeric Nanocarriers Delivery of Gefitinib: Formulation, In vitro and In vivo Characterization” authored by Navya Sree Kola Srinivas, Ruchi Verma, Girish Pai Kulyadi and Lalit Kumar* published International Journal of Nanomedicine. 2017:12:15-28. This award received on 09th February 2019 at KMC Greens, Manipal Academy of Higher Education (MAHE), Manipal, Udupi, Karnataka, during Manipal College of Pharmaceutical Sciences, Annual Day and award function.
  7. Best e-poster award for “Development of felodipine solid dispersion containing oral films for the enhancement of solubility and dissolution rate” presented in 24th Annual National Convention of Association of Pharmaceutical Teachers of India (APTICON 2019), held in Oct 11-13, 2019 at DIT University, Dehradun, Uttarakhand, India.
  8. Best e-oral presentation award for “A novel formulation to enhance the Lamotrigine bioavailability and drug concentration in brain” presented on 11th & 12th December 2020 in National Level Virtual Conference (11th Dravyaka 2020) organized by Teja Education Society Sponsoring Geethanjali College of Pharmacy, Telangana, India in Association with APTI Telangana State Branch.
  9. Received “Young Scientist Award” from “Society of Pharmaceutical Education & Research (SPER)” during the 10th Annual International Conference & Exhibition [SPER 2021] held at Ganpat University, Mehsana on 08th – 09th October 2021.
  10. Won Second Place in “Grand Challenge 2021” conducted by Manipal-Government of Karnataka Bioincubator, MAHE, Manipal, Karanataka, India held between 17th November 2021 to 3rd December 2021.
  11. Received “Young Scientist Award” in International Conference on Emerging Trends and Artificial Intelligence in Pharmaceutical, Biomedical Science and Technology, organized by Career Point School of Pharmacy, CPU, Kota, Rajasthan on 04th March 2022.
  12. Received “Researcher of the Year Award” Instituted by Dr N Udupa, Former Director – Research (Health Sciences), MAHE, Manipal for the academic year 2020-21, during Awards & Annual Day of MCOPS, MAHE, Manipal, Udupi, Karnataka, India on 27th April 2022.

Patents Filed:

  1. Lalit Kumar, Naga Thirumalesh Chevala, and Chamallamudi Mallikarjuna Rao. Drug sealant and method of synthesis thereof.
  2. Lalit Kumar, Naga Thirumalesh Chevala, and Suresh Muthuramalingam. A formulation for therapeutic insert and process thereof.
  3. Lalit Kumar, and Salwa. A dissolving micro-needle array comprising Remdesivir loaded nanostructured lipid carriers and a method for preparing thereof.
  4. Lalit Kumar, Navya Ajitkumar Bhaskaran, Srinivas Reddy Jitta, and Salwa. An oral formulation for cancer and method of synthesis thereof.

Research Publications

  1. Srinivas Reddy Jitta, Salwa, Navya Ajitkumar Bhaskaran, Shirleen Miriam Marques, Lalit Kumar*, Sri Pragnya Cherkuk, Vanishree Rao, Pravesh Sharma, Onkar Prakash Kulkarni. Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers – recommending its dose reduction. Drug Delivery and Translational Research. 2023; In Press. (2021 Impact Factor 5.671).
  2. Sana, Salwa, Rupesh Kalidas Shirodkar, Lalit Kumar*, Ruchi Verma. Enhancement of solubility and dissolution rate using tailored rapidly dissolving oral films containing felodipine solid dispersion: In vitro characterization and ex vivo J Pharm Innovation. 2013; In Press. (2021 Impact Factor 2.538).
  3. RJA Vibhavari, Vanishree Rao, Gautam Kumar, Suman Manandhar, Sri Pragnya Cheruku, Priya Bisht, Mallikarjuna Rao Chamallmudi, Krishnadas Nandakumar, Lalit Kumar, Nitesh Kumar*. Brain-targeted nano-architectures for efficient drug delivery and sensitization in glioblastoma. Current Pharmaceutical Design. 2023; In Press. (2021 Impact Factor 3.310).
  4. RJA Vibhavari, Vanishree Rao, Sri Pragnya Cheruku, Harish Kumar, B. Swastika Maity, Krishnadas Nandakumar, Lalit Kumar, Chetan Mehta, Usha Nayak, Mallikarjuna Rao Chamallamudi, Nitesh Kumar. Enhancing temozolomide antiglioma response by inhibiting O6-methylguanine-DNA methyltransferase with selected phytochemicals: In silico and in vitro approach. 3 Biotech. 2023; In Press. (2021 Impact Factor 2.893).
  5. Shashank Agni, Jobin Jose*, Sanjay R Ugare, Lalit Kumar, Kartik Bhairu Khot. Design, characterization and evaluation of novel mucoadhesive nasal inserts for the treatment of hypertension. Tenside Surfactants Detergents. 2023; In Press. (2021 Impact Factor 1.058).
  6. Navya Ajitkumar Bhaskaran, Srinivas Reddy Jitta, Salwa, Lalit Kumar*, Pravesh Sharma, Onkar Prakash Kulkarni, Gangadhar Hari, Karthik Gourishetti, Ruchi Verma, Sumit Raosaheb Birangal, Vijaya Bhaskar K. Folic acid – chitosan functionalized polymeric nanocarriers to treat colon cancer. Int J Biological Macromolecules. 2023;253(5):127142. (2022 Impact Factor 8.200).
  7. Shirleen Miriam Marques, Lalit Kumar*. Factors affecting the preparation of nanocrystals: Characterization, surface modifications and toxicity aspects. Expert Opinion on Drug Delivery. 2023;20(7):871-894. (2021 Impact Factor 8.129).
  8. Shirleen Miriam Marques, Salwa, Lalit Kumar*. QbD-based developed of an eco-friendly HPLC method for the estimation of nisoldipine in nano-formulations: Forced degradation studies and in-vitro release studies. Sustainable Chemistry and Pharmacy. 2023;36:101254. (2022 Impact Factor 6.000).
  9. Salwa, Lalit Kumar*. Quality-by-design driven analytical method (AQbD) development and validation of HPLC-UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies. Microchemical Journal. 2023;193:108944. (2021 Impact Factor 5.304).
  10. Shirleen Miriam Marques, Rupesh K Shirodkar, Lalit Kumar*. Analytical ‘Quality-by-Design’ paradigm in development of a RP-HPLC method for the estimation of cilnidipine in nanoformulations: Forced degradation studies and mathematical modeling of in-vitro release studies. Microchemical Journal. 2023;193:109124. (2021 Impact Factor 5.304).
  11. Sonal Mehrotra, Salwa, Pavan Kalyan BG, Navya Ajitkumar Bhaskaran, Srinivas Reddy Jitta, Lalit Kumar*. Nose-to brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach. Journal of Drug Delivery Science and Technology. 2023;87:104833. (2022 Impact Factor 5.000).
  12. Richa Mahesh Natekar, Cleona Elizabeth Mary DCruz, Lalit Kumar*, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar*. Felodipine-loaded spanlastics: Superior nanocarriers for transdermal delivery. Tenside Surfactants Detergents. 2023;60(4):296-311. (2021 Impact Factor 1.058).
  13. Ashveta Anant Dessai, Mrunali Navin Kantak, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar*. Formulation and characterization of nano-particulate drug carrier system for lacidipine. Assay and Drug Development Technologies. 2023;21(7):309-324. (2022 Impact Factor 1.800).
  14. Mrunali Navin Kantak, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidash Shirodkar. Oral gastroretentive film of lacidipine for the treatment of gastroparesis. Assay and Drug Development Technologies. 2023;21:97-109. (2021 Impact Factor 2.471).
  15. Pavan Kalyan BG, Sonal Mehrotra, Shirleen Miriam Marques, Lalit Kumar*, Ruchi Verma. 3D printing in personalized medicines: A focus on applications of the technology. Materials Today Communications. 2023;35:105875. (2021 Impact Factor 3.662).
  16. Salika Santosh Mapari, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar. Formulation and characterisation of lacidipine niosomal gel for transdermal delivery. Tenside Surfactants Detergents. 2023;60(2):124-139. (2021 Impact Factor 1.058).
  17. Srinivas Reddy Jitta, Arunima Chauhan, Vanessa Vaz, Lalit Kumar*. Development and validation of HPLC method for quantification of hesperetin in a topical formulation. India Journal of Pharmaceutical Sciences. 2023;85(3):678-685. (2021 Impact Factor 0.664).
  18. Vivek P. Chavda, Anjali Pandya, Lalit Kumar, Nidhi Raval, Lalitkumar K Vora, Sreeranjini Pulakkat, Vandana Patravale, Salwa, Yanhong Duo, Ben Zhong Tang. Exosome nanovesicles: A potential carrier for therapeutic delivery. Nano Today. 2023;49:101771. (2021 Impact Factor 18.962).
  19. Sonal Mehrotra, Salwa, Lalit Kumar*. Implementation of QbD in formulation development of nanocarrier based drug delivery systems. Critical ReviewsTM in Therapeutic Drug Delivery Carriers. 2023;40(3):1-46. (2021 Impact Factor 4.889).
  20. Shirleen Miriam Marques, Dikshita Ullas Chavan, Prashant Jivaji Bhide, Madhusudan Joshi, Lalit Kumar*, Rupesh Kalidas Shidorkar*. Novel Luliconazole spanlastic nanocarriers: Development and characterization. Current Drug Delivery. 2023;20(6):792-806. (2020 Impact Factor 2.565).
  21. Renjith P Johnson, Chandrahas Koumar Ratnacaram, Lalit Kumar, Jobin Jose*. Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer. Drug Resistance Updates. 2022;64:100865. (2021 Impact Factor 22.841).
  22. Naga Thirumalesh Chevala, Jenica Alwin Dsouza, Hitesh Saini, Lalit Kumar*. Design and development of tranexamic acid loaded film-forming gel to alleviate melasma. J Cosmetic Dermatology. 2022;21(12):6863-6874. (2020 Impact Factor 2.696).
  23. Naga Thirumalesh Chevala, Lalit Kumar*, Vimal Veetilvalappil, Aranjani Jesil Mathew, Manali Jadhav, Mayuri Gandhi, C Mallikarjuna Rao. Multifunctional and multilayer surgical sealant for a better safety. Int J Pharmaceutics. 2022;629:122411. (2021 Impact Factor 6.510).
  24. Srinivas Reddy Jitta, Salwa, Navya Ajitkumar Bhaskaran, Shirleen Miriam Marques, Lalit Kumar. Recent advance in nanoformulation development of ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS. Expert Opinion on Drug Delivery. 2022;19(9):1133-1148. (2021 Impact Factor 8.129).
  25. Sajeeda S, Kumar L, Verma R*. An overview of analytical methods for the estimation of propofol in pharmaceutical formulations, biological matrices and hair marker. Critical Rev Analyt Chem. 2022;52(7):1694-1701. https://org/10.1080/10408347.2021.1910927. (2021 Impact Factor 5.686).
  26. Sajeeda S, Kumar L, Verma R*. Lamotrigine – A review of analytical methods developed for pharmaceutical formulations and biological matrices. Critical Rev Analyt Chem. 2022;52(7):1451-1460. https://doi.org/10.1080/10408347.2021.1886901. (2021 Impact Factor 5.686).
  27. Neha Benedicta Fernandes, Raghavendra Udaya Kumar Shenoy, Mandira Kashi Kajampady, Cleona EM DCruz, Rupesh K Shirodkar, Lalit Kumar*, Ruchi Verma. Fullerene for the treatment of cancer: An emerging tool. Environmental Sci Pollution Res. 2022;39(29):58607-58627. (2021 Impact Factor 5.190).
  28. Gayatri Gopal Shetgaonkar, Shirleen Miriam Marques, Cleona EM DCruz, RJA Vibhavari, Lalit Kumar*, Rupesh Kalidas Shirodkar. Exosomes as a cell derivative carrier in the diagnosis and treatment of central nervous system diseases. Drug Delivery and Translational Research. 2022;12:1047-1079. https://doi.org/10.1007/s13346-021-01026-0. (2021 Impact Factor 5.671).
  29. Pavan Kalyan BG, Lalit Kumar*. 3D Printing: Applications in Tissue Engineering, Medical Devices and Drug Delivery. AAPS PharmSciTech. 2022;23:92. (2021 Impact Factor 4.026).
  30. Apoorva Ratnakar Barve, Gauri Ramchandra Kapileshwari, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Anand Avinash Mahajan, Asmita Sunil Arondekar, Rupesh Kalidas Shirodkar. Solubility enhancement of ebastine by formulating microemulsion using D-optimal mixture design: Optimization and characterization. Assay and Drug Development Technologies. 2022;20(6):258-273. (2021 Impact Factor 2.471).
  31. Anjali Ambalal Purohit, Dikshita Ullas Chavan, Shirleen Miriam Marques, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar*. Formulation and evaluation of a novel cubosomal emulgel for topical delivery of luliconazole. Tenside Surfactants Detergents. 2022;59(5):373-382. (2021 Impact Factor 1.058).
  32. Shifali D Kumari, Naga Thirumalesh Chevala, Srinivas Reddy Jitta, Lalit Kumar*, Ruchi Verma, Jobin Jose. Design and development of naringin loaded proposomal gel for wound healing. Journal of Cosmetic Dermatology. 2022;21(10):5187-5202. (2021 Impact Factor 2.189).
  33. Navya Ajitkumar Bhaskaran, Srinivas Reddy Jitta, Salwa, SriPragnya Cheruku, Nitesh Kumar, Lalit Kumar*. Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations. International Journal of Biological Macromolecules. 2022;211:301-315. (2021 Impact Factor 8.023).
  34. Naga Thirumalesh Chevala, Lalit Kumar*, Vimal Veetilvalappil, Aranjani Jesil Mathew, Bemma Paonam, Ganesh Mohan, Shamee Shastry, Krishnan Balasubramanian, C Mallikarjuna Rao. Nanoporous and nanothickness film-forming bioactive composition for biomedical applications. Scientific Reports. 2022;12:8198. Pages 19. (2021 Impact Factor 4.996).
  35. Navya Ajitkumar Bhaskaran, Salwa, Amanda Velinna Fernandes, Gabriela Volfová, Chinna Raja Pydi, Lalit Kumar*, Ruchi Verma, Shirleen Miriam Marques, Rupesh Kalidas Shirodkar. Development of cream to enhance the antifungal activity and reduce the side effects of fluconazole for the treatment of candida albicans. Tenside Surfactants Detergents. 2022;59(3):231-239. (2021 Impact Factor 1.058).
  36. Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Salwa, Lalit Kumar*. Anti-oxidant containing nanostructured lipid carriers of ritonavir: Development, optimization, in vitro and in vivo AAPS PharmSciTech. 2022;23:88. (2021 Impact Factor 4.026).
  37. DCruz Cleona Elizabeth Mary, Bhide Prashant Jivaji, Kumar Lalit*, Shirodkar Rupesh Kalidas**. Novel nano spanlastic carrier system for buccal delivery of lacidipine. J Drug Delivery Sci Technol. 2022;68:103061. (2021 Impact Factor 5.062).
  38. Prabhu Ankitha, Jose Jose, Kumar Lalit, Salwa S, Kumar M Vijay, Nabavi Seyed Mohammad. Transdermal delivery of curcumin-loaded solid lipid nanoparticles as microneedle patch: An in vitro and in vivo AAPS PharmSciTech. 2022;23(1):49. Pages 12. DOI: 10.1208/s12249-021-02186-5. (2021 Impact Factor 4.026).
  39. Chevala Naga Thirumalesh, Muthuramalingam Suresh, Kumar Lalit*, Rao C Mallikarjuna. Nanoporous scaffold fabrication for biomedical application by employing probe sonication. Materials Today: Proceedings. 2022;55(1):94-97.
  40. Tejasvini CS, Sekhar S, Verma* R, Kumar L. Development and validation of stability indicating assay RP-HPLC method for the estimation of anidulafungin and related compounds in parenteral dosage form. Rasayan Journal of Chemistry. 2022;15(1):280-287.
  41. Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Lalit Kumar*, Rupesh K Shirodkar. Development and validation of RP-HPLC method for quantification of total, free and entrapped ritonavir in lipid nanocarriers and drug content of film coated fixed dose formulation. Indian Journal of Pharmaceutical Education and Research. 2022;56(3S):S547-558. (2021 Impact Factor 0.843).
  42. Salwa, Lalit Kumar*. Engrafted stem cell therapy for Alzheimer’s disease: A promising treatment strategy with clinical outcome. Journal of Controlled Release. 2021;338:837-857. (2020 Impact Factor 9.776).
  43. Salwa, Naga Thirmalesh Chevala, Srinivas Reddy Jitta, Shirleen Miriam Marques, Vanessa Marcia Vaz, Lalit Kumar*. Polymeric microneedles for transdermal delivery of nanoparticles: Frontiers of formulation, sterility and stability aspects. Journal of Drug Delivery Science and Technology. 2021;65:102711. (2020 Impact Factor 3.981).
  44. Navya Ajitkumar Bhaskaran, Lalit Kumar*. Treating colon cancers with a non-conventional strategic approach: An overview of various nanoparticulate systems. Journal of Controlled Release. 2021;336:16-39. (2020 Impact Factor 9.776).
  45. Tejasvini Sai Chebrolu, Lalit Kumar, Ruchi Verma. Lacidipine: Review of analytical methods developed for pharmaceutical dosage forms and biological fluids. Bioanalysis. 2021;13(12):1011-1024. (2020 Impact Factor 2.681).
  46. Vanessa Marcia Vaz, Lalit Kumar*. 3D printing as a promising tool in personalized medicine. AAPS PharmSciTech. 2021;22:49. DOI: 10.1208/s12249-020-01905-8. (2020 Impact Factor 3.246).
  47. Vanessa Marcia Vaz, Srinivas Reddy Jitta, Ruchi Verma, Lalit Kumar*. Hesperetin loaded proposomal gel for topical antioxidant activity. Journal of Drug Delivery Science and Technology. 2021;66:102873. (2020 Impact Factor 3.981).
  48. Srinivas Reddy Jitta, Salwa, Lalit Kumar*, Puja K Gangurde, Ruchi Verma. Development and validation of HPLC method for the quantification of Remdesivir in intravenous dosage form. Assay and Drug Development Technologies. 2021;19(8):475-483. (2020 Impact Factor 1.738).
  49. Navya Ajitkumar Bhaskaran, Lalit Kumar*, M Sreenivasa Reddy, Girish Pai K. An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in injectable formulation. Acta Pharmaceutica. 2021;71(1):57-79. (2020 Impact Factor 2.230).
  50. K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma. Atom based 3D QSAR and fingerprint based 2D QSAR of novel molecules a MmpL3 receptor inhibitors for Mycobacterium tuberculosis. Research Journal of Pharmacy and Technology. 2021;14(12):6321-6329.
  51. K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma. 3D Atom based QSAR model of DprE1 inhibitor as anti-tubercular agents. Research Journal of Pharmacy and Technology. 2021;14(11):5903-5910.
  52. Karthik Gourishetti, Raghuvir Keni, Pawan Ganesh Nayak, Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Lalit Kumar, Nitesh Kumar, Nandakumar Krishnadas, Rekha Shenoy*. Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats. International Journal of Nanomedicine. 2020;15:9265-9282. (2020 Impact Factor 6.400).
  53. Shikha Y Singh, Salwa, Rupesh K Shirodkar, Ruchi Verma, Lalit Kumar*. Enhancement in dissolution rate of atorvastatin trihydrate calcium by formulating its porous tablet using sublimation technique. Journal of Pharmaceutical Innovation. 2020;15(4):498-520. (2020 Impact Factor 2.750).
  54. Dikshita Ullas Chavan, Shirleen Miriam Marques, Prashant Jivaji Bhide, Lalit Kumar**, Rupesh Kalidas Shirodkar*. Rapidly dissolving felodipine nanoparticle strips – Formulation using design of experiment and characterisation. Journal of Drug Delivery Science and Technology. 2020;60:102053. (2018 Impact Factor 2.734).
  55. Gauri Ramchandra Kapileshwari, Apoorva Ratnakar Barve, Lalit Kumar, Prashant Jivaji Bhide, Madhusudan Joshi, Rupesh Kalidas Shirodkar. Novel drug delivery system of Luliconazole – Formulation and characterisation. Journal of Drug Delivery Science and Technology. 2020;55:101302. (2018 Impact Factor 2.734).
  56. Puja K Gangurde, Navya Ajitkumar Bhaskaran, Ruchi Verma, Jobin Jose, Lalit Kumar*. Analytical method development using central composite design for estimation of lamotrigine in lipid nanoformulation. Materiale Prastice. 2020;57(1):223-235. (2018 Impact Factor 1.393).
  57. Amanda Velinna Fernandes, Chinna Raja Pydi, Ruchi Verma, Jobin Jose, Lalit Kumar*. Design, preparation and in vitro characterizations of fluconazole loaded nanostructured lipid carriers. Brazilian Journal of Pharmaceutical Sciences. 2020;56:e18069. (2017 Impact Factor 0.483).
  58. Somaraju Revanth Kumar, Vignesh Mohan, K Srilekha, Shifa Ryaz, KB Koteshwara*, Vamshi Krishna Tippavajhala, Lalit Kumar. Diffusion studies of diclofenac sodium topical gel using different synthetic membranes. Research Journal of Pharmacy and Technology. 2020;13(7):3098-3102.
  59. Lohith TN, Lalit Kumar, Ruchi Verma*. Design, molecular design, ADME analysis and molecular dynamics studies of novel acetylated Schiff base as COX-2 inhibitors. Research Journal of Pharmacy and Technology. 2020;13(4):1901-1906.
  60. Divya Harmalkar, Soraiya Godinho, Prashant Jivaji Bhide, Lalit Kumar, Rupesh Kalidas Shirodkar. New formulation technique for solubility and dissolution rate enhancement of poorly soluble drugs. Pharmaceutical Chemistry Journal. 2019;53(8):720-729. (2017 Impact Factor 0.679).
  61. Soraiya Godinho, Divya Harmalkar, Lalit Kumar, Rupesh Kalidas Shirodkar. Formulation and characterization of gastroretentive mucoadhesive tablets for treatment of gastroparesis. Pharmaceutical Chemistry Journal. 2019;52(3):230-8. (2017 Impact Factor 0.679).
  62. Shweta Shetty, Jobin Jose*, Lalit Kumar, R Narayan Charyulu. Novel ethosomal gel of clove oil for the treatment of cutaneous candidiasis. Journal of Cosmetic Dermatology. 2019;18(3):862-9. (2017 Impact Factor 1.520).
  63. Puja K Gangurde, Navya Ajitkumar B, Lalit Kumar*. Lamotrigine lipid nanoparticles for effective treatment of epilepsy: A focus on brain targeting via nasal route. Journal of Pharmaceutical Innovation. 2019;14:91-111. (2017 Impact Factor 1.934).
  64. Abhishek S Dhoot, Gasper J Fernandes, Anup Naha, Mahalaxmi Rathnanand, Lalit Kumar*. Design of experiments in pharmaceutical development. Pharmaceutical Chemistry Journal. 2019;53(8):730-735. (2017 Impact Factor 0.679).
  65. Rupesh K Shirodkar, Lalit Kumar, Srinivas Mutalik, Shaila Angela Lewis. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers – Emerging Lipid Based Drug Delivery Systems. Pharmaceutical Chemistry Journal. 2019;53(5):440-453. (2017 Impact Factor 0.679).
  66. Vamshi Krishna Tippavjhala, Lalit Kumar, Muddukrishna Badamane Sathyanarayana, Girish Thunga, Viji Pulikkel Chandran, Sohil Khan, Girish Pai Kulyadi*. A critical and comparative study on patient informative leaflet, primary label and primary carton of a carbapenem dry powder injectable. Indian Journal of Pharmaceutical Education and Research. 2019;53(01):178-85. (2017 Impact Factor 0.351).
  67. Siddhesh Ghatwal, Divya Harmalkar, Soraiya Godinho, Lalit Kumar, Rupesh K Shirodkar*. Development of thermoreversible in situ nasal gel using chitosan as a mucoadhesive agent for prophylaxis of migraine. Latin American Journal of Pharmacy. 2018;37(12):2365-72. (2017 Impact Factor 0.401).
  68. Astrilia Larisa Estibeiro, Divya Harmalkar, Soraiya Godinho, Lalit Kumar, Rupesh Kalidas Shirodkar*. Lacidipine porous tablets: Formulation and in vitro Latin American Journal of Pharmacy. 2018;37(9):1764-71. (2017 Impact Factor 0.401).
  69. Zenab Attari, Lalit Kumar, C Mallikarjuna Rao, KB Koteshwara. Reversed phase – HPLC method for determination of temozolomide in rat plasma and brain: Simple, sensitive and robust method. Pharmaceutical Chemistry Journal. 2018;52(3):266-70. (2017 Impact Factor 0.679).
  70. Lalit Kumar, Ruchi Verma*. Design, drug likeness and molecular docking of novel molecules for antitubercular activity. Latin American Journal of Pharmacy. 2018;37(4):759-67. (2017 Impact Factor 0.401).
  71. Ekta Naik, Divya Harmalkar, Soraiya Godinho, Lalit Kumar, Shaila Lewis, Rupesh Kalidas Shirodkar*. Liquisolid technique using tween 80 and sodium starch glycolate to enhance the solubility and dissolution rate of an antihypertensive drug. Latin American Journal of Pharmacy. 2018;37(4):717-26. (2017 Impact Factor 0.401).
  72. Lalit Kumar, Ranamalla Saketh Reddy, Chinna Raja Pydi, Vamshi Krishna T, Muddukrishna B S, Girish Pai K*. A research on market complaint product: detailed investigation and a report on broken film coated tablet inside an intact blister pack. Latin American Journal of Pharmacy. 2018;37(2):363-7. (2017 Impact Factor 0.401).
  73. Shikha Y Singh, Ruchi Verma, Lalit Kumar*. Porous oral drug delivery system – Tablets. Pharmaceutical Chemistry Journal. 2018;52(6):553-61. (2017 Impact Factor 0.679).
  74. Gasper J. Fernandes, Lalit Kumar, Karthik Sharma, Rupa Tunge, Mahalaxmi Rathnanand*. A review on solubility enhancement of carvedilol – A BCS class II drug. Journal of Pharmaceutical Innovation. 2018;13:197-212. (2017 Impact Factor 1.934).
  75. R Saketh Reddy, Lalit Kumar*, Chinna Raja Pydi, M Sreenivasa Reddy, Ruchi Verma. Development of fluconazole suppositories for the treatment of candida infection of genitourinary tract. Indian Journal of Pharmaceutical Education and Research. 2018;52(4S):S16-22. (2017 Impact Factor 0.351).
  76. Amanda Velinna Fernandes, Chinna Raja Pydi, Girish Pai K, Ruchi Verma, Lalit Kumar*. Development and validation of an HPLC analytical method for the detection and quantification of nicardipine in lipid nanoparticles. Latin American Journal of Pharmacy. 2017;36(10):1995-2000. (2017 Impact Factor 0.401).
  77. Navya Sree KS, Girish Pai K, Ruchi Verma, Padiyar Ananthakrishna, Lalit Kumar*. Validation of HPLC method for quantitative determination of gefitinib in polymeric nanoformulation. Pharmaceutical Chemistry Journal. 2017;51(2):105-9. (2017 Impact Factor 0.679).
  78. Atari Z, Rao C Mallikarjuna, Kumar Lalit, Koteshwara KB*. Temozolomide and its stability – A critical factor. Advanced Science Letters. 2017;23(3):1841-5.
  79. Navya Sree, KS, Ruchi Verma, Girish Pai K, Lalit Kumar*. A quality by design (QbD) approach on polymeric nanocarrier delivery of gefitinib: Formulation, in vitro and in vivo International Journal of Nanomedicine. 2017;12:15-28. (2017 Impact Factor 4.300).
  80. Lalit Kumar, Yugvijay Singh Yadav, Mahalaxmi Rathnanand*. Simultaneous determination of linezolid and levamisole hydrochloride in a fixed dose combination. Indian Journal of Pharmaceutical Education and Research. 2017;51(4):613-9. (2017 Impact Factor 0.351).
  81. Sreenivasa Reddy, L Kumar*, Z Attari, R Verma. Statistical optimization of extraction process for the quantification of valsartan in rabbit plasma by a HPLC method. Indian Journal of Pharmaceutical Sciences. 2017;79(1):16-28 (2017 Impact Factor 0.738).
  82. Lalit Kumar, Ruchi Verma*. Molecular docking based approach for the design of Novel Flavone Analogues as inhibitor of Beta-Hydroxyacyl-ACP Dehydratase HadAB complex. Research Journal of Pharmacy and Technology. 2017;10(8):2439-45.
  83. Managuli RS, Kumar L, Chonkar AD, Shirodkar RK, Lewis S, Koteshwara KB, Reddy MS, Mutalik S. Development and validation of stability-indicating RP-HPLC method by statistical optimization process for the quantification of asenapine maleate in lipidic nanoformulations. Journal of Chromatographic Science. 2016;54(8):1290-300. (2017 Impact Factor 1.037).
  84. Attari Z, Kumar L, Rao CM, Koteshwara KB. Validation of a sensitive and robust reversed phase – HPLC method for determination of temozolomide. Latin American Journal of Pharmacy. 2016;35(5):967-71. (2017 Impact Factor 0.401).
  85. Dareka T, Aithal KS, Shirodkar R, Zenab A, Kumar L, Lewis S. Characterization and in vivo evaluation of lacidipine inclusion complexes with β-cyclodextrin and its derivatives. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2016;84(3-4):226-35. (2017 Impact Factor 1.316).
  86. Lalit Kumar*, Meka Sreenivasa Reddy, Ruchi Verma, KB Koteshwara. Selection of cryoprotective agent for freeze drying of valsartan solid lipid nanoparticles. Latin American Journal of Pharmacy. 2016;35(2):284-90. (2017 Impact Factor 0.401).
  87. Rupesh K Shirodkar, Lalit Kumar, Chandrasekhar Misra, Renuka Managuli, Zenab Attari, Srinivasa Mutalik, Shaila A Lewis*. Development and validation of a reverse phase HPLC method for the estimation of lacidipine in rat plasma: Application to preclinical pharmacokinetics. Latin American Journal of Pharmacy. 2016;35(1):124-9. (2017 Impact Factor 0.401).
  88. Muddukrishna BS, Vamshi Krishna T, Lalit Kumar, M Sreenivasa Reddy, Thunga Girish, Girish Pai K. Personnel Hygiene in Pharmaceuticals: Its importance and requirements for personnel involved in the manufacturing of quality medicines. Research Journal of Pharmacy and Technology. 2016;9(10):1647-9.
  89. Lalit Kumar, Sreyas, Ruchi Verma. Determination of saturated solubility of propranolol using UV visible spectrophotometer. Der Pharmacia Lettre 2016;8(17):196-201.
  90. Rupesh K Shirodkar, Pallavi Shetty, Lalit Kumar, Srinivasa Mutalik, Shaila Lewis*. Development and validation of a reverse phase HPLC method for the estimation of lacidipine in nanoformulations. Latin American Journal of Pharmacy. 2015;34(6):1162-6. (2017 Impact Factor 0.401).
  91. Lalit Kumar*, M Sreenivasa Reddy, Renuka S Managuli, Girish Pai K. Full Factorial Design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles. Saudi Pharmaceutical Journal. 2015;23(5):549-55. (2017 Impact Factor 3.110).
  92. Lalit Kumar, BS Suhas, Girish Pai K, Ruchi Verma. Determination of saturated solubility of naproxen using UV visible spectrophotometer. Research Journal of Pharmacy and Technology. 2015;8(7):825-8.
  93. Vamshi Krishna T, Lalit Kumar, M Sreenivasa Reddy, Rajat Rao, M Ankineedu, Girish Pai K. Investigation to find out the root cause for presence of broken tablet in the marketed blister pack. Research Journal of Pharmacy and Technology. 2015;8(6):707-9.
  94. Vamshi Krishna T, Lalit Kumar, M Sreenivasa Reddy, Muddukrishna BS, Girish Pai K. Process deviations in pharmaceutical industry: Various types, handling procedure and systems. Research Journal of Pharmacy and Technology. 2014;7(3):340-342.
  95. L Kumar*, MS Reddy, RK Shirodkar, GK Pai, VT Krishna, R Verma. Preparation and characterization of Fluconazole vaginal films for the treatment of vaginal Indian Journal of Pharmaceutical Sciences. 2013;75(5):585-90. (2017 Impact Factor 0.738).
  96. Arkendu Chatterjee*, Lalit Kumar, Benoy Brata Bhowmik and Amlan Gupta. Microparticulated anti-HIV vaginal gel: In vitro in vivo drug release and vaginal irritation study. Pharmaceutical Development and Technology. 2011;16(5):466-73. (2017 Impact Factor 1.945).

Book Edited:

  • Lalit Kumar and Yashwant Pathak. Nanocarriers for Drug Targeting Brain Tumors. Publisher: Elsevier, USA. June 2022. ISBN No. 978-0-323-90773-6.

 Book Chapters Contributed:

  1. Cleona Elizabeth Mary DCruz, Rupesh Kalidas Shirodkar, Yashwant Pathak, Lalit Kumar*. Nanoparticles for brain tumor imaging and therapy. In: Smart Nanomaterials for Drug Delivery and Neurological Diseases Management. Singapore: Springer Nature Singapore Pte Ltd. 2023. In Press.
  2. Swathy KK, Ruchi Verma, Lalit Kumar*. Ethylene-vinyl acetate foam. In: Polymeric foams: Materials, technology and applications. United States: American Chemical Society (ACS). 2023. In Press.
  3. Shirleen Miriam Marques and Lalit Kumar*. Improving the sustainability of bio-based products using nanotechnology. In: Sustainable Nanotechnology: Strategies, products and applications. Edited by: Yashwant Pathak, Govindan Parayil and Jayvadan Patel. New York: John Wiley and Sons. 2022. pp. 51-70. ISBN: 978-1-119-64997-7.
  4. Srinivas Reddy Jitta and Lalit Kumar*. Solid lipid nanoparticles based drug and gene delivery to macrophages. In: Macrophage targeted delivery systems: Basic concepts and therapeutic applications. Edited by: Swati Gupta and Yashwant V Pathak. New York: Springer Inc. 2022. pp. 203-224. ISBN: 978-3-030-84163-8.
  5. Shirleen Miriam Marques and Lalit Kumar*. PKPD of PLGA-PEG-PLGA-triblock co-polymeric micelles. In: Pharmacokinetics and Pharmacodynamics of nanoparticulate drug delivery systems (NPDDS). Edited by: Jayvadan Patel and Yashwant V Pathak. Switzerland: Springer. 2022. pp. 273-292. ISBN No. 978-3-030-83394-7.
  6. Navya Ajitkumar Bhaskaran and Lalit Kumar*. Solid lipid nanoparticles based drug delivery for targeting brain tumours. In: Nanocarriers for drug targeting brain tumors. Edited by: Lalit Kumar and Yashwant Pathak. United States: Elsevier. 2022. pp. 237-268. ISBN No. 978-0-323-90773-6.
  7. Srinivas Reddy Jitta and Lalit Kumar*. Nanostructured lipid carriers as an alternative carrier with high drug loading for targeting to brain tumors. In: Nanocarriers for drug targeting brain tumors. Edited by: Lalit Kumar and Yashwant Pathak. United States: Elsevier. 2022. pp. 269-298. ISBN No. 978-0-323-90773-6.
  8. Shirleen Miriam Marques and Lalit Kumar*. Mechanism of polymeric micelles for drug targeting to brain tumours. In: Nanocarriers for drug targeting brain tumors. Edited by: Lalit Kumar and Yashwant Pathak. United States: Elsevier. 2022. pp. 367-400. ISBN No. 978-0-323-90773-6.
  9. Salwa and Lalit Kumar*, Yashwant Pathak. Experts opinion on current challenges and future directions. In: Nanocarriers for drug targeting brain tumours. Edited by: Lalit Kumar and Yashwant Pathak. United States: Elsevier. 2022. pp. 777-796. ISBN No. 978-0-323-90773-6.
  10. Gayatri Gopal Shetgaonkar and Lalit Kumar*. Mitigating radiation effects on humans during space travel: Recent development. In: Handbook of space pharmaceuticals. Edited by: Yashwant V Pathak, Marlise Araújo dos Santos and Luis Zea. Singapore: Springer Nature Singapore Pte Ltd. 2022. pp. 577-609. ISBN No. 978-3-030-05527-1.
  11. Salwa and Lalit Kumar*. Microfluidics technology for nanoparticles and equipment. In: Emerging technologies for nanoparticle manufacturing. Edited by: Jayvadan Patel and Yashwant Pathak. Switzerland: Springer Nature. 2021. pp. 67-98. ISBN No. 978-3-030-50703-9.
  12. Srinivas Reddy Jitta and Lalit Kumar*. Salting out and ionic gelation manufacturing techniques for nanoparticles. In: Emerging technologies for nanoparticle manufacturing. Edited by: Jayvadan Patel and Yashwant Pathak. Switzerland: Springer Nature. 2021. pp. 129-166. ISBN No. 978-3-030-50703-9.
  13. Gayatri Gopal Shetgaonkar and Lalit Kumar*. Ultrasound activated nanoparticles. In: Emerging technologies for nanoparticle manufacturing. Edited by: Jayvadan Patel and Yashwant Pathak. Switzerland: Springer Nature. 2021. pp. 301-332. ISBN No. 978-3-030-50703-9.
  14. Gayatri Gopal Shetgaonkar and Lalit Kumar*. Engineered nanomaterials and pharmacokinetics. In: Nano-Pharmacokinetics: Advancing cancer therapy. Edited by: Nanasaheb D Thorat and Nitesh Kumar. United Kingdom: Elsevier. 2021. pp. 71-92. ISBN: 978-0-323-85050-6.
  15. Salwa and Lalit Kumar*. Molecular mechanisms to understand aging, immune function and nutraceutical interventions. In: Nutraceuticals for aging and anti-aging: Basic understanding and clinical evidence. Edited by: Jayant Nemchand Lokhande and Yashwant Vishnupant Pathak. CRC Press, Boca Rattan Florida (Part of Taylor and Francis). 2021. pp. 205-224. ISBN No. 978-0-367-61494-2.
  16. Navya Ajitkumar Bhaskaran, Naga Thirumalesh Chevala and Lalit Kumar*. Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship. In: Nanomedicines for breast cancer theranostics. Edited by Nanasaheb D Thorat and Joanna Bauer. United States: Elsevier. 2020. pp. 245-268. ISBN No. 978-0-12-820016-2.
  17. Gayatri Gopal Shetgaonkar and Lalit Kumar*. Chemistry of neurochemicals – Psychopharmaceuticals and neuropeptides. In: Principles of neurochemistry: Fundamentals and applications. Edited by: Bijo Mathew and Della Grace Thomas Parambi. Singapore: Springer Nature Singapore Pte Ltd. 2020. pp. 41-70. ISBN No. 978-981-15-5166-6.
  18. Salwa and Lalit Kumar*. Revisiting Alzheimer’s disease. In: Principles of neurochemistry: Fundamentals and applications. Edited by: Bijo Mathew and Della Grace Thomas Parambi. Singapore: Springer Nature Singapore Pte Ltd. 2020. pp. 137-155. ISBN No. 978-981-15-5166-6.
  19. Lalit Kumar* and M Sreenivasa Reddy. Semisolid Dosage forms. In: An insight into Industrial Technology. Edited by Dr. N. Udupa, Dr. M. Sreenivasa Reddy and Dr. Usha Y. Nayak. Bengaluru: Prism Books Pvt. Ltd., 2014. pp. 105 – 140. ISBN No. 978-81-7286-740-9.
  20. Lalit Kumar* and M Sreenivasa Reddy. Intrauterine Devices. In: Recent Trends in Novel Drug Delivery. Edited by Dr. N. Udupa and Dr. Srinivas Mutalik. Bengaluru: Prism Books Pvt. Ltd., 2014. pp. 227 – 240. ISBN No. 978-81-7286-742-3.
  21. Lalit Kumar*, S.T. Bhagawati and Rupesh Kalidas Shirodkar. Oral Controlled Drug Delivery System. In: Recent Trends in Novel Drug Delivery. Edited by Dr. N. Udupa and Dr. Srinivas Mutalik. Bengaluru: Prism Books Pvt. Ltd., 2014. pp. 168 – 189. ISBN No. 978-81-7286-742-3.
  22. Lalit Kumar* and M Sreenivasa Reddy. Applications of nanotechnology in healthcare. In: Exploring Nanotechnology in Healthcare. Edited by Dr. N. Udupa. Manipal: Manipal University Press. 2013. pp. 100-146.

  Research Profiles: Scopus author id: https://www.scopus.com/authid/detail.uri?authorId=56373155300 Google scholar link: https://scholar.google.com/citations?user=NMvdgtYAAAAJ&hl=en Orcid link: https://orcid.org/0000-0002-2418-9712.